on April 12, 2007
Published online before print April 12, 2007, doi: 10.1161/STROKEAHA.106.473983
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 29, 2006
From the Long Island College Hospital, Department of Neurology, and State University of New York Health Sciences Center, Downstate Campus, Brooklyn, NY (N.J.); the Zeenat Qureshi Stroke Research Center (A.I.Q.), University of Minnesota, Minneapolis, Minn; Columbia University Medical Center (A.N.), Department of Surgery, New York, NY; and the National Institutes of Neurological Disorders and Stroke, Office of Minority Health and Research, National Institutes of Health, Bethesda, Md (J.K.L.) * To whom correspondence should be addressed. E-mail: NJanjua{at}chpnet.org.
Background and Purpose--Few pediatric reports of thrombolysis exist. We sought to determine national rates of thrombolysis among pediatric ischemic stroke patients using a national database. Methods--Patients between the ages of 1 and 17 years, entered in the Nationwide Inpatient Sample between 2000 and 2003, with International Classification of Diseases codes for ischemic stroke were included in the study. Differences in mean age, gender distribution, ethnicity, secondary diagnoses, medical complications, associated procedure rates, modes of discharge, and hospital costs between pediatric stroke patients receiving and not receiving thrombolysis were estimated. Results--In the United States, between 2000 and 2003 an estimated 2904 children were admitted with ischemic stroke, of which 46 children (1.6%) received thrombolytic therapy. Children who received thrombolysis were on the average older (11 versus 9 years), more likely to be male (100% versus 53.8%), with significantly higher hospital costs ($81 800 versus $38 700). These children were also less likely to be discharged home with higher rates of death and dependency, although differences in clinical severity between the 2 groups was not known. Conclusion--Thrombolysis, though not indicated for patients <18 years of age, is currently being administered to children, with unclear benefit. Larger studies are needed to evaluate the safety and efficacy of this treatment for children.
Revised on November 14, 2006
Accepted on November 17, 2006
Thrombolysis for Ischemic Stroke in Children. Data From the Nationwide Inpatient Sample
Nazli Janjua MD*;
Key words: ischemic • pediatric • stroke • thrombolysis
Related Article:
Stroke 2007 38: 1722-1723.
This article has been cited by other articles:
 |
|
 |
|
  Y. Shen, M. Drum, and S. Roth The Prevalence of Perioperative Visual Loss in the United States: A 10-Year Study from 1996 to 2005 of Spinal, Orthopedic, Cardiac, and General Surgery Anesth. Analg., November 1, 2009; 109(5): 1534 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Perkins, J. Stephens, H. Xiang, and W. Lo The Cost of Pediatric Stroke Acute Care in the United States Stroke, August 1, 2009; 40(8): 2820 - 2827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Putaala, T. M. Metso, A. J. Metso, E. Makela, E. Haapaniemi, O. Salonen, M. Kaste, and T. Tatlisumak Thrombolysis in Young Adults With Ischemic Stroke Stroke, June 1, 2009; 40(6): 2085 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arnold, M. Steinlin, A. Baumann, K. Nedeltchev, L. Remonda, S. J. Moser, M.-L. Mono, G. Schroth, H. P. Mattle, and R. W. Baumgartner Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature Stroke, March 1, 2009; 40(3): 801 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Pappachan and F J Kirkham Cerebrovascular disease and stroke Arch. Dis. Child., October 1, 2008; 93(10): 890 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Heil, L. Malinowski, A. Rinderknecht, J. P. Broderick, and D. Franz Use of Intravenous Tissue Plasminogen Activator in a 16-Year-Old Patient with Basilar Occlusion J Child Neurol, September 1, 2008; 23(9): 1049 - 1053. [Abstract] [PDF]
|
|
|
|
|
|
H. T. Whelan, J. D. Cook, C. M. Amlie-Lefond, C. A. Hovinga, A. K. Chan, R. N. Ichord, G. A. deVeber, and P. F. Thall Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children Stroke, September 1, 2008; 39(9): 2627 - 2636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young Stroke, September 1, 2008; 39(9): 2644 - 2691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lo, K. Zamel, K. Ponnappa, A. Allen, D. Chisolm, M. Tang, B. Kerlin, and K. O. Yeates The Cost of Pediatric Stroke Care and Rehabilitation Stroke, January 1, 2008; 39(1): 161 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Belvis Thrombolysis for Acute Stroke in Pediatrics Stroke, June 1, 2007; 38(6): 1722 - 1723. [Full Text] [PDF]
|
|